Related Experiment Videos
Epidemic spread and antigenic variability of Neisseria meningitidis
1Max-Planck Institut für molekulare Genetik, Berlin, Germany.
Trends in Microbiology
|May 1, 1995
Abstract:
Genetic variation of cell-surface antigens of serogroup A meningococci arises from horizontal genetic exchange. Most clonal variants are lost by clonal reduction during epidemic and pandemic spread, but in exceptional cases, genetic variants are rapidly fixed in the bacterial population by clonal replacement.
Insights
Genetic variation in meningococci (Neisseria meningitidis) is driven by horizontal gene transfer. While most variants are lost, some rapidly replace others during epidemics, shaping bacterial populations.
Area of Science:
- Microbiology
- Genetics
- Epidemiology
Background:
- Serogroup A *Neisseria meningitidis* (meningococcus) causes significant morbidity and mortality globally.
- Understanding the genetic mechanisms driving meningococcal evolution is crucial for effective disease control.
Purpose of the Study:
- To investigate the role of horizontal genetic exchange in generating cell-surface antigen variation in serogroup A meningococci.
- To elucidate the population dynamics, specifically clonal reduction and replacement, that influence the fate of genetic variants during epidemics.
Main Methods:
- Analysis of genetic variation in *Neisseria meningitidis* populations.
- Population genetics approaches to study clonal dynamics during epidemic spread.
Main Results:
- Horizontal genetic exchange is a primary driver of cell-surface antigen diversity in serogroup A meningococci.
- Clonal reduction frequently eliminates genetic variants during epidemic and pandemic spread.
- Exceptional cases demonstrate rapid fixation of genetic variants through clonal replacement, leading to population-level shifts.
Conclusions:
- Genetic variation and subsequent population dynamics, particularly clonal replacement, are key factors in the evolution and epidemic potential of serogroup A meningococci.
- These findings have implications for vaccine development and public health strategies targeting meningococcal disease.